Wells Fargo Remains a Buy on Medtronic (MDT)
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...
SiliconRepublic27d
Gclinics: Improving healthcare by making genetic testing accessible
She has a master’s degree in molecular medicine from Trinity College Dublin ... Medical and corporate healthcare companies like Abbott Laboratories, where I honed my expertise in molecular ...
Krabbe Disease Treatment Markets, Companies, and Growth Opportunities 2024-2030 - Advancements in Gene Therapy Expand Addressable Market
The "Krabbe Disease Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's ...
$12.5 Bn Influenza Vaccine Market To 2032 By Vaccine Type, Technology, Age Group, Route Of Administration, And Region
The "Influenza Vaccine market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global ...
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
Abbott Laboratories (ABT) Gets a Buy from Wells Fargo
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...
Abbott Laboratories stock underperforms Wednesday when compared to competitors
The stock's fall snapped a two-day winning streak.
Abbott Laboratories stock outperforms competitors on strong trading day
Abbott Laboratories closed $4.01 short of its 52-week high ($121.64), which the company reached on March 8th.
AOL6d
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...